Showing results (111-120 of 123) with videos related to
Sort By:
Pageof 13
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
Integrating Pulmonary and Systemic Transcriptomic Profiles to Characterize Lung Injury after Pediatric Hematopoietic Stem Cell TransplantEmma M Pearce, Erica Evans, Madeline Y Mayday, et al.Haematologica|March 18, 2017
Improved survival after acute graft-versus-host disease diagnosis in the modern eraHanna J Khoury, Tao Wang, Michael T Hemmer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2021
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHDBenjamin Watkins, Muna Qayed, Courtney McCracken, et al.JCI Insight|July 22, 2025
Integrating pulmonary and systemic transcriptomes to characterize lung injury after pediatric hematopoietic stem cell transplantEmma M Pearce, Erica Evans, Madeline Y Mayday, et al.Blood|October 8, 2025
Distinct Biological Subtypes of Chronic GVHD after Pediatric Hematopoietic Cell TransplantationBernard Ng, Andrew C Harris, Sayeh Abdossamadi, et al.Transplantation and Cellular Therapy|October 1, 2025
Identification of Distinct Subtypes in Immune Tolerance after Hematopoietic Cell Transplantation Using the Prospective ABLE1.0 Pediatric Study CohortBernard Ng, Andrew C Harris, Sayeh Abdossamadi, et al.Medrxiv : the Preprint Server for Health Sciences|December 11, 2023
Pulmonary microbiome and transcriptome signatures reveal distinct pathobiologic states associated with mortality in two cohorts of pediatric stem cell transplant patientsMatt S Zinter, Christopher C Dvorak, Madeline Y Mayday, et al.Blood Advances|March 24, 2025
Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapyHannah Lust, Liora M Schultz, Soyang Kwon, et al.Nature Medicine|May 23, 2024
Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantationMatt S Zinter, Christopher C Dvorak, Madeline Y Mayday, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 29, 2018
Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic TransplantationSaurabh Chhabra, Ying Liu, Michael T Hemmer, et al.Pageof 13